AAM sounds alarm on ‘unsustainable, race to the bottom’ for generics and biosimilars

Summary

The American Association of Manufacturers (AAM) issued a warning about unsustainable pricing pressure in the generics and biosimilars industry, stating that economic conditions have deteriorated to the point where industry sustainability is at risk.